Skip to main content
Suzhou Zelgen Biopharmaceuticals Co.,Ltd. (SHA:688266)
China flag China · Delayed Price · Currency is CNY
114.65
+0.11 (0.10%)
Jun 6, 2025, 2:45 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 2018
Pharmaceutical
383.56M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Growth
27.14%
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Intermediates and Raw Materials
2.81M
Log In
Log In
Log In
Log In
Upgrade
Pharmaceutical Intermediates and Raw Materials Growth
342.17%
Log In
Log In
Log In
Log In
Upgrade
Asset Licensing
76.45K
Log In
Log In
Log In
Log In
Upgrade
Asset Licensing Growth
-
Log In
Log In
Log In
Log In
Upgrade
Technical Service
-
Log In
Log In
Log In
Log In
Upgrade
R & D and Clinical Trials Examination Drugs Service
-
Log In
Log In
Log In
Log In
Upgrade
R & D and Clinical Trials Examination Drugs Service Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '18 2018
China
386.44M
Log In
Log In
Log In
Log In
Upgrade
China Growth
27.83%
Log In
Log In
Log In
Log In
Upgrade
Overseas
-
Log In
Log In
Log In
Log In
Upgrade